(8R,9S)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazin-3-one
CAS: 1207456-00-5
Ref. 3D-FF103523
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued |
Product Information
Name:
(8R,9S)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazin-3-one
Description:
Talazoparib is a potent DNA methyltransferase inhibitor that has been shown to inhibit the activity of breast and ovarian cancer cells. It does not have any cytotoxic effects on normal cells, which makes it a promising drug for cancer treatment. Talazoparib inhibits the enzyme DNA methyltransferase, preventing the transfer of methyl groups to dna and rna. This inhibition prevents cell proliferation and induces apoptosis in cancer cells. Talazoparib is currently being developed as a potential anticancer drug for platinum-resistant ovarian cancer.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
380.35 g/mol
Formula:
C19H14F2N6O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
